WHO Says It Is Trying to Expedite Mpox Vaccination in DRC – But Faces Multiple Hurdles 24/03/2024 Elaine Ruth Fletcher WHO officials said that they are trying to expedite delivery of mpox vaccines to outbreak-stricken DR Congo through talks with the world’s only two mpox vaccine manufacturers, as well as appeals for vaccine donations and negotiations with DRC officials. But speaking at a press briefing on Thursday, WHO’s Dr Mike Ryan, Executive Director of Health […] Continue reading -> Challenging the Status Quo: Six Steps Towards Empowering Communities in Global Health 23/03/2024 Maayan Hoffman What actions and strategies are required for countries and communities to have more agency in their health? This is the topic of the latest episode of the Global Health Matters “Dialogues” podcast series, in which host Dr. Garry Aslanyan tries to “blow up some of the echo chambers that exist in global health.” In this […] Continue reading -> Pharma Pivot on Pandemic Agreement: ‘Free Access’ to Pathogens in Exchange for ‘Binding Obligation’ on Equity 21/03/2024 Elaine Ruth Fletcher Pharmaceutical giants could support a formula whereby companies are guaranteed free and immediate access to pathogens with pandemic potential in exchange for binding equity agreements as part of a proposed World Health Organization (WHO) pandemic agreement, says a leading industry figure. The statement by Thomas Cueni, director-general of the International Federation of Pharmaceutical Manufacturers […] Continue reading -> Fight Against TB Gets Boost From Artificial Intelligence and Innovative Financing 21/03/2024 Kerry Cullinan Tuberculosis has long been the neglected stepchild of global health – but new diagnostic tools and treatments, artificial intelligence (AI) and debt swaps to help countries meet their targets have come into play and are making a difference. “There is fresh momentum,” says Dr Jamie Tonsing, Senior TB advisor at the Global Fund, in a […] Continue reading -> Wake-Up Call: Lessons Learned from Poland must Reaffirm TB as an EU Health Priority 21/03/2024 Krzysztof Herboczek & Joanna Ladomirska Over the last century, Europe – including Northern, Western, Southern and Central European countries – made remarkable progress in the near elimination of tuberculosis (TB) due to improved socio-economic conditions and advancements in research and development. However, a recent surge of TB in Europe, coupled with lack of structural preparedness within many European Union (EU) […] Continue reading -> From Mpox to Measles: Are We Living in The Age of Disease Outbreaks? 19/03/2024 Kerry Cullinan Discussion about disease outbreaks dominated the biannual meeting of the Strategic Advisory Group of Experts on Immunization (SAGE) – which its chairperson described as “alarming” as the aim of the group is to ensure early vaccination to prevent outbreaks. “The outbreak-related recommendations is a sign that normalcy is starting to be living with outbreaks,” warned Dr Hanna […] Continue reading -> Indian Pharma Companies Under Investigation For Poor Drug Quality Donate Millions to Political Parties 19/03/2024 Editorial team Seven Indian pharmaceutical companies made donations to domestic political parties while they were under investigation for substandard drug production, according to an investigation published in Scroll. The companies named in the investigation included Hetero Labs and Hetero Healthcare, Torrent Pharma, Zydus Healthcare, Glenmark, Cipla, IPCA Laboratories Limited, and Intas Pharmaceutical. They were under investigation for […] Continue reading -> Africa’s Battle Against HIV and AIDS Needs US Commitment 19/03/2024 Jean Kaseya Twenty years ago, the sight of women, men and children being carried to hospitals in wheelbarrows as they clung to the fragile threads of life, was heartbreakingly common. AIDS was not just a disease. It was a shadow of despair that loomed over our communities, threatening to engulf us in darkness. But then, in a […] Continue reading -> Sudan to Start Polio Immunisation as Six African Countries Detect Virus 18/03/2024 Kerry Cullinan Sudan will resume immunising children against polio after detecting circulating vaccine-derived poliovirus type 2 (cVDPV2) in its waster water, as six other African countries have reported either cases or positive environmental samples over the past two weeks. Mali and Nigeria reported one case each, Yemen reported three cases and Angola, Côte d’Ivoire and Sierra Leone […] Continue reading -> WHO Assurance on Drug Resistance to Key HIV Drug, Dolutegravir; New Trial Shows Promise With TB Treatment 14/03/2024 Kerry Cullinan The World Health Organization (WHO) recently reported drug resistance to the world’s gold-standard antiretroviral medicine, dolutegravir “exceeding levels observed in clinical trials” – with resistance ranging from 3.9% to 19.6%. This was potentially very bad news as dolutegravir has been the recommended first- and second-line HIV treatment for all population groups since 2018 – but […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Challenging the Status Quo: Six Steps Towards Empowering Communities in Global Health 23/03/2024 Maayan Hoffman What actions and strategies are required for countries and communities to have more agency in their health? This is the topic of the latest episode of the Global Health Matters “Dialogues” podcast series, in which host Dr. Garry Aslanyan tries to “blow up some of the echo chambers that exist in global health.” In this […] Continue reading -> Pharma Pivot on Pandemic Agreement: ‘Free Access’ to Pathogens in Exchange for ‘Binding Obligation’ on Equity 21/03/2024 Elaine Ruth Fletcher Pharmaceutical giants could support a formula whereby companies are guaranteed free and immediate access to pathogens with pandemic potential in exchange for binding equity agreements as part of a proposed World Health Organization (WHO) pandemic agreement, says a leading industry figure. The statement by Thomas Cueni, director-general of the International Federation of Pharmaceutical Manufacturers […] Continue reading -> Fight Against TB Gets Boost From Artificial Intelligence and Innovative Financing 21/03/2024 Kerry Cullinan Tuberculosis has long been the neglected stepchild of global health – but new diagnostic tools and treatments, artificial intelligence (AI) and debt swaps to help countries meet their targets have come into play and are making a difference. “There is fresh momentum,” says Dr Jamie Tonsing, Senior TB advisor at the Global Fund, in a […] Continue reading -> Wake-Up Call: Lessons Learned from Poland must Reaffirm TB as an EU Health Priority 21/03/2024 Krzysztof Herboczek & Joanna Ladomirska Over the last century, Europe – including Northern, Western, Southern and Central European countries – made remarkable progress in the near elimination of tuberculosis (TB) due to improved socio-economic conditions and advancements in research and development. However, a recent surge of TB in Europe, coupled with lack of structural preparedness within many European Union (EU) […] Continue reading -> From Mpox to Measles: Are We Living in The Age of Disease Outbreaks? 19/03/2024 Kerry Cullinan Discussion about disease outbreaks dominated the biannual meeting of the Strategic Advisory Group of Experts on Immunization (SAGE) – which its chairperson described as “alarming” as the aim of the group is to ensure early vaccination to prevent outbreaks. “The outbreak-related recommendations is a sign that normalcy is starting to be living with outbreaks,” warned Dr Hanna […] Continue reading -> Indian Pharma Companies Under Investigation For Poor Drug Quality Donate Millions to Political Parties 19/03/2024 Editorial team Seven Indian pharmaceutical companies made donations to domestic political parties while they were under investigation for substandard drug production, according to an investigation published in Scroll. The companies named in the investigation included Hetero Labs and Hetero Healthcare, Torrent Pharma, Zydus Healthcare, Glenmark, Cipla, IPCA Laboratories Limited, and Intas Pharmaceutical. They were under investigation for […] Continue reading -> Africa’s Battle Against HIV and AIDS Needs US Commitment 19/03/2024 Jean Kaseya Twenty years ago, the sight of women, men and children being carried to hospitals in wheelbarrows as they clung to the fragile threads of life, was heartbreakingly common. AIDS was not just a disease. It was a shadow of despair that loomed over our communities, threatening to engulf us in darkness. But then, in a […] Continue reading -> Sudan to Start Polio Immunisation as Six African Countries Detect Virus 18/03/2024 Kerry Cullinan Sudan will resume immunising children against polio after detecting circulating vaccine-derived poliovirus type 2 (cVDPV2) in its waster water, as six other African countries have reported either cases or positive environmental samples over the past two weeks. Mali and Nigeria reported one case each, Yemen reported three cases and Angola, Côte d’Ivoire and Sierra Leone […] Continue reading -> WHO Assurance on Drug Resistance to Key HIV Drug, Dolutegravir; New Trial Shows Promise With TB Treatment 14/03/2024 Kerry Cullinan The World Health Organization (WHO) recently reported drug resistance to the world’s gold-standard antiretroviral medicine, dolutegravir “exceeding levels observed in clinical trials” – with resistance ranging from 3.9% to 19.6%. This was potentially very bad news as dolutegravir has been the recommended first- and second-line HIV treatment for all population groups since 2018 – but […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Pharma Pivot on Pandemic Agreement: ‘Free Access’ to Pathogens in Exchange for ‘Binding Obligation’ on Equity 21/03/2024 Elaine Ruth Fletcher Pharmaceutical giants could support a formula whereby companies are guaranteed free and immediate access to pathogens with pandemic potential in exchange for binding equity agreements as part of a proposed World Health Organization (WHO) pandemic agreement, says a leading industry figure. The statement by Thomas Cueni, director-general of the International Federation of Pharmaceutical Manufacturers […] Continue reading -> Fight Against TB Gets Boost From Artificial Intelligence and Innovative Financing 21/03/2024 Kerry Cullinan Tuberculosis has long been the neglected stepchild of global health – but new diagnostic tools and treatments, artificial intelligence (AI) and debt swaps to help countries meet their targets have come into play and are making a difference. “There is fresh momentum,” says Dr Jamie Tonsing, Senior TB advisor at the Global Fund, in a […] Continue reading -> Wake-Up Call: Lessons Learned from Poland must Reaffirm TB as an EU Health Priority 21/03/2024 Krzysztof Herboczek & Joanna Ladomirska Over the last century, Europe – including Northern, Western, Southern and Central European countries – made remarkable progress in the near elimination of tuberculosis (TB) due to improved socio-economic conditions and advancements in research and development. However, a recent surge of TB in Europe, coupled with lack of structural preparedness within many European Union (EU) […] Continue reading -> From Mpox to Measles: Are We Living in The Age of Disease Outbreaks? 19/03/2024 Kerry Cullinan Discussion about disease outbreaks dominated the biannual meeting of the Strategic Advisory Group of Experts on Immunization (SAGE) – which its chairperson described as “alarming” as the aim of the group is to ensure early vaccination to prevent outbreaks. “The outbreak-related recommendations is a sign that normalcy is starting to be living with outbreaks,” warned Dr Hanna […] Continue reading -> Indian Pharma Companies Under Investigation For Poor Drug Quality Donate Millions to Political Parties 19/03/2024 Editorial team Seven Indian pharmaceutical companies made donations to domestic political parties while they were under investigation for substandard drug production, according to an investigation published in Scroll. The companies named in the investigation included Hetero Labs and Hetero Healthcare, Torrent Pharma, Zydus Healthcare, Glenmark, Cipla, IPCA Laboratories Limited, and Intas Pharmaceutical. They were under investigation for […] Continue reading -> Africa’s Battle Against HIV and AIDS Needs US Commitment 19/03/2024 Jean Kaseya Twenty years ago, the sight of women, men and children being carried to hospitals in wheelbarrows as they clung to the fragile threads of life, was heartbreakingly common. AIDS was not just a disease. It was a shadow of despair that loomed over our communities, threatening to engulf us in darkness. But then, in a […] Continue reading -> Sudan to Start Polio Immunisation as Six African Countries Detect Virus 18/03/2024 Kerry Cullinan Sudan will resume immunising children against polio after detecting circulating vaccine-derived poliovirus type 2 (cVDPV2) in its waster water, as six other African countries have reported either cases or positive environmental samples over the past two weeks. Mali and Nigeria reported one case each, Yemen reported three cases and Angola, Côte d’Ivoire and Sierra Leone […] Continue reading -> WHO Assurance on Drug Resistance to Key HIV Drug, Dolutegravir; New Trial Shows Promise With TB Treatment 14/03/2024 Kerry Cullinan The World Health Organization (WHO) recently reported drug resistance to the world’s gold-standard antiretroviral medicine, dolutegravir “exceeding levels observed in clinical trials” – with resistance ranging from 3.9% to 19.6%. This was potentially very bad news as dolutegravir has been the recommended first- and second-line HIV treatment for all population groups since 2018 – but […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Fight Against TB Gets Boost From Artificial Intelligence and Innovative Financing 21/03/2024 Kerry Cullinan Tuberculosis has long been the neglected stepchild of global health – but new diagnostic tools and treatments, artificial intelligence (AI) and debt swaps to help countries meet their targets have come into play and are making a difference. “There is fresh momentum,” says Dr Jamie Tonsing, Senior TB advisor at the Global Fund, in a […] Continue reading -> Wake-Up Call: Lessons Learned from Poland must Reaffirm TB as an EU Health Priority 21/03/2024 Krzysztof Herboczek & Joanna Ladomirska Over the last century, Europe – including Northern, Western, Southern and Central European countries – made remarkable progress in the near elimination of tuberculosis (TB) due to improved socio-economic conditions and advancements in research and development. However, a recent surge of TB in Europe, coupled with lack of structural preparedness within many European Union (EU) […] Continue reading -> From Mpox to Measles: Are We Living in The Age of Disease Outbreaks? 19/03/2024 Kerry Cullinan Discussion about disease outbreaks dominated the biannual meeting of the Strategic Advisory Group of Experts on Immunization (SAGE) – which its chairperson described as “alarming” as the aim of the group is to ensure early vaccination to prevent outbreaks. “The outbreak-related recommendations is a sign that normalcy is starting to be living with outbreaks,” warned Dr Hanna […] Continue reading -> Indian Pharma Companies Under Investigation For Poor Drug Quality Donate Millions to Political Parties 19/03/2024 Editorial team Seven Indian pharmaceutical companies made donations to domestic political parties while they were under investigation for substandard drug production, according to an investigation published in Scroll. The companies named in the investigation included Hetero Labs and Hetero Healthcare, Torrent Pharma, Zydus Healthcare, Glenmark, Cipla, IPCA Laboratories Limited, and Intas Pharmaceutical. They were under investigation for […] Continue reading -> Africa’s Battle Against HIV and AIDS Needs US Commitment 19/03/2024 Jean Kaseya Twenty years ago, the sight of women, men and children being carried to hospitals in wheelbarrows as they clung to the fragile threads of life, was heartbreakingly common. AIDS was not just a disease. It was a shadow of despair that loomed over our communities, threatening to engulf us in darkness. But then, in a […] Continue reading -> Sudan to Start Polio Immunisation as Six African Countries Detect Virus 18/03/2024 Kerry Cullinan Sudan will resume immunising children against polio after detecting circulating vaccine-derived poliovirus type 2 (cVDPV2) in its waster water, as six other African countries have reported either cases or positive environmental samples over the past two weeks. Mali and Nigeria reported one case each, Yemen reported three cases and Angola, Côte d’Ivoire and Sierra Leone […] Continue reading -> WHO Assurance on Drug Resistance to Key HIV Drug, Dolutegravir; New Trial Shows Promise With TB Treatment 14/03/2024 Kerry Cullinan The World Health Organization (WHO) recently reported drug resistance to the world’s gold-standard antiretroviral medicine, dolutegravir “exceeding levels observed in clinical trials” – with resistance ranging from 3.9% to 19.6%. This was potentially very bad news as dolutegravir has been the recommended first- and second-line HIV treatment for all population groups since 2018 – but […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Wake-Up Call: Lessons Learned from Poland must Reaffirm TB as an EU Health Priority 21/03/2024 Krzysztof Herboczek & Joanna Ladomirska Over the last century, Europe – including Northern, Western, Southern and Central European countries – made remarkable progress in the near elimination of tuberculosis (TB) due to improved socio-economic conditions and advancements in research and development. However, a recent surge of TB in Europe, coupled with lack of structural preparedness within many European Union (EU) […] Continue reading -> From Mpox to Measles: Are We Living in The Age of Disease Outbreaks? 19/03/2024 Kerry Cullinan Discussion about disease outbreaks dominated the biannual meeting of the Strategic Advisory Group of Experts on Immunization (SAGE) – which its chairperson described as “alarming” as the aim of the group is to ensure early vaccination to prevent outbreaks. “The outbreak-related recommendations is a sign that normalcy is starting to be living with outbreaks,” warned Dr Hanna […] Continue reading -> Indian Pharma Companies Under Investigation For Poor Drug Quality Donate Millions to Political Parties 19/03/2024 Editorial team Seven Indian pharmaceutical companies made donations to domestic political parties while they were under investigation for substandard drug production, according to an investigation published in Scroll. The companies named in the investigation included Hetero Labs and Hetero Healthcare, Torrent Pharma, Zydus Healthcare, Glenmark, Cipla, IPCA Laboratories Limited, and Intas Pharmaceutical. They were under investigation for […] Continue reading -> Africa’s Battle Against HIV and AIDS Needs US Commitment 19/03/2024 Jean Kaseya Twenty years ago, the sight of women, men and children being carried to hospitals in wheelbarrows as they clung to the fragile threads of life, was heartbreakingly common. AIDS was not just a disease. It was a shadow of despair that loomed over our communities, threatening to engulf us in darkness. But then, in a […] Continue reading -> Sudan to Start Polio Immunisation as Six African Countries Detect Virus 18/03/2024 Kerry Cullinan Sudan will resume immunising children against polio after detecting circulating vaccine-derived poliovirus type 2 (cVDPV2) in its waster water, as six other African countries have reported either cases or positive environmental samples over the past two weeks. Mali and Nigeria reported one case each, Yemen reported three cases and Angola, Côte d’Ivoire and Sierra Leone […] Continue reading -> WHO Assurance on Drug Resistance to Key HIV Drug, Dolutegravir; New Trial Shows Promise With TB Treatment 14/03/2024 Kerry Cullinan The World Health Organization (WHO) recently reported drug resistance to the world’s gold-standard antiretroviral medicine, dolutegravir “exceeding levels observed in clinical trials” – with resistance ranging from 3.9% to 19.6%. This was potentially very bad news as dolutegravir has been the recommended first- and second-line HIV treatment for all population groups since 2018 – but […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
From Mpox to Measles: Are We Living in The Age of Disease Outbreaks? 19/03/2024 Kerry Cullinan Discussion about disease outbreaks dominated the biannual meeting of the Strategic Advisory Group of Experts on Immunization (SAGE) – which its chairperson described as “alarming” as the aim of the group is to ensure early vaccination to prevent outbreaks. “The outbreak-related recommendations is a sign that normalcy is starting to be living with outbreaks,” warned Dr Hanna […] Continue reading -> Indian Pharma Companies Under Investigation For Poor Drug Quality Donate Millions to Political Parties 19/03/2024 Editorial team Seven Indian pharmaceutical companies made donations to domestic political parties while they were under investigation for substandard drug production, according to an investigation published in Scroll. The companies named in the investigation included Hetero Labs and Hetero Healthcare, Torrent Pharma, Zydus Healthcare, Glenmark, Cipla, IPCA Laboratories Limited, and Intas Pharmaceutical. They were under investigation for […] Continue reading -> Africa’s Battle Against HIV and AIDS Needs US Commitment 19/03/2024 Jean Kaseya Twenty years ago, the sight of women, men and children being carried to hospitals in wheelbarrows as they clung to the fragile threads of life, was heartbreakingly common. AIDS was not just a disease. It was a shadow of despair that loomed over our communities, threatening to engulf us in darkness. But then, in a […] Continue reading -> Sudan to Start Polio Immunisation as Six African Countries Detect Virus 18/03/2024 Kerry Cullinan Sudan will resume immunising children against polio after detecting circulating vaccine-derived poliovirus type 2 (cVDPV2) in its waster water, as six other African countries have reported either cases or positive environmental samples over the past two weeks. Mali and Nigeria reported one case each, Yemen reported three cases and Angola, Côte d’Ivoire and Sierra Leone […] Continue reading -> WHO Assurance on Drug Resistance to Key HIV Drug, Dolutegravir; New Trial Shows Promise With TB Treatment 14/03/2024 Kerry Cullinan The World Health Organization (WHO) recently reported drug resistance to the world’s gold-standard antiretroviral medicine, dolutegravir “exceeding levels observed in clinical trials” – with resistance ranging from 3.9% to 19.6%. This was potentially very bad news as dolutegravir has been the recommended first- and second-line HIV treatment for all population groups since 2018 – but […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Indian Pharma Companies Under Investigation For Poor Drug Quality Donate Millions to Political Parties 19/03/2024 Editorial team Seven Indian pharmaceutical companies made donations to domestic political parties while they were under investigation for substandard drug production, according to an investigation published in Scroll. The companies named in the investigation included Hetero Labs and Hetero Healthcare, Torrent Pharma, Zydus Healthcare, Glenmark, Cipla, IPCA Laboratories Limited, and Intas Pharmaceutical. They were under investigation for […] Continue reading -> Africa’s Battle Against HIV and AIDS Needs US Commitment 19/03/2024 Jean Kaseya Twenty years ago, the sight of women, men and children being carried to hospitals in wheelbarrows as they clung to the fragile threads of life, was heartbreakingly common. AIDS was not just a disease. It was a shadow of despair that loomed over our communities, threatening to engulf us in darkness. But then, in a […] Continue reading -> Sudan to Start Polio Immunisation as Six African Countries Detect Virus 18/03/2024 Kerry Cullinan Sudan will resume immunising children against polio after detecting circulating vaccine-derived poliovirus type 2 (cVDPV2) in its waster water, as six other African countries have reported either cases or positive environmental samples over the past two weeks. Mali and Nigeria reported one case each, Yemen reported three cases and Angola, Côte d’Ivoire and Sierra Leone […] Continue reading -> WHO Assurance on Drug Resistance to Key HIV Drug, Dolutegravir; New Trial Shows Promise With TB Treatment 14/03/2024 Kerry Cullinan The World Health Organization (WHO) recently reported drug resistance to the world’s gold-standard antiretroviral medicine, dolutegravir “exceeding levels observed in clinical trials” – with resistance ranging from 3.9% to 19.6%. This was potentially very bad news as dolutegravir has been the recommended first- and second-line HIV treatment for all population groups since 2018 – but […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Africa’s Battle Against HIV and AIDS Needs US Commitment 19/03/2024 Jean Kaseya Twenty years ago, the sight of women, men and children being carried to hospitals in wheelbarrows as they clung to the fragile threads of life, was heartbreakingly common. AIDS was not just a disease. It was a shadow of despair that loomed over our communities, threatening to engulf us in darkness. But then, in a […] Continue reading -> Sudan to Start Polio Immunisation as Six African Countries Detect Virus 18/03/2024 Kerry Cullinan Sudan will resume immunising children against polio after detecting circulating vaccine-derived poliovirus type 2 (cVDPV2) in its waster water, as six other African countries have reported either cases or positive environmental samples over the past two weeks. Mali and Nigeria reported one case each, Yemen reported three cases and Angola, Côte d’Ivoire and Sierra Leone […] Continue reading -> WHO Assurance on Drug Resistance to Key HIV Drug, Dolutegravir; New Trial Shows Promise With TB Treatment 14/03/2024 Kerry Cullinan The World Health Organization (WHO) recently reported drug resistance to the world’s gold-standard antiretroviral medicine, dolutegravir “exceeding levels observed in clinical trials” – with resistance ranging from 3.9% to 19.6%. This was potentially very bad news as dolutegravir has been the recommended first- and second-line HIV treatment for all population groups since 2018 – but […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Sudan to Start Polio Immunisation as Six African Countries Detect Virus 18/03/2024 Kerry Cullinan Sudan will resume immunising children against polio after detecting circulating vaccine-derived poliovirus type 2 (cVDPV2) in its waster water, as six other African countries have reported either cases or positive environmental samples over the past two weeks. Mali and Nigeria reported one case each, Yemen reported three cases and Angola, Côte d’Ivoire and Sierra Leone […] Continue reading -> WHO Assurance on Drug Resistance to Key HIV Drug, Dolutegravir; New Trial Shows Promise With TB Treatment 14/03/2024 Kerry Cullinan The World Health Organization (WHO) recently reported drug resistance to the world’s gold-standard antiretroviral medicine, dolutegravir “exceeding levels observed in clinical trials” – with resistance ranging from 3.9% to 19.6%. This was potentially very bad news as dolutegravir has been the recommended first- and second-line HIV treatment for all population groups since 2018 – but […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Assurance on Drug Resistance to Key HIV Drug, Dolutegravir; New Trial Shows Promise With TB Treatment 14/03/2024 Kerry Cullinan The World Health Organization (WHO) recently reported drug resistance to the world’s gold-standard antiretroviral medicine, dolutegravir “exceeding levels observed in clinical trials” – with resistance ranging from 3.9% to 19.6%. This was potentially very bad news as dolutegravir has been the recommended first- and second-line HIV treatment for all population groups since 2018 – but […] Continue reading -> Posts navigation Older postsNewer posts